Trade deficit data, Federal Reserve officials' remarks, earnings from Pfizer, Disney, Uber, and additional companies.

The pharmaceutical industry has long protested the idea of globally linked drug prices as a threat to years of U.S. dominance ...

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the ...

We’ll see another busy week for earnings , with reports also coming from BioNTech, GlobalFoundries, Rivia, Occidental, and ...

With semaglutide patents set to expire in 2026, Indian pharma giants are ramping up peptide production and device tie-ups to ...

President Donald Trump just sent letters to heads of 17 major pharmaceutical companies pushing them to drop drug prices in ...

VHT is attractively valued at 16x forward earnings, but sector momentum is weak and technicals remain bearish. Read why VHT ...

As Wall Street embarks on the first full week of August, the earnings wave continues with another stacked week of reports ...

The pharmaceutical industry continues to evolve rapidly, driven by innovation, global health challenges, and technological ...

AbbVie ( ABBV) on Thursday recorded better-than-expected financials for Q2 2025 and raised its full-year earnings outlook as the company’s newer immunology drugs offset a sharp sales decline for its ...

Concerns over US economic growth have taken center stage despite a solid corporate earnings season from S&P 500 companies.